Importantly, our findings herein on T cell metabolic function, cytotoxicity, and migratory velocity highlight the immediate translational relevance of the fructose/GLUT5 metabolic axis for optimizing fuel selection in T cell-based therapies against cancer, and position GLUT5 as a novel means to selectively fuel CAR-T cells. The gene discussed is SLC2A5; the disease is cancer.